Targeted delivery of antisense oligonucleotides to parenchymal liver cells in vivo.
Biessen
E A
EA
Division of Biopharmaceutics, Leiden/Amsterdam Center for Drug Research, Leiden University, The Netherlands.
Vietsch
H
H
Rump
E T
ET
Fluiter
K
K
Bijsterbosch
M K
MK
van Berkel
T J
TJ
D000818:Animals; D001212:Asialoglycoproteins / Q000378:metabolism; D001682:Biological Availability; D004337:Drug Carriers; D016503:Drug Delivery Systems / Q000379:methods*; D004355:Drug Stability; D006020:Glycopeptides; D008099:Liver / Q000166:cytology / Q000187:drug effects*; D008565:Membrane Proteins; D020319:Oligodeoxyribonucleotides, Antisense / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics; D009961:Orosomucoid / Q000378:metabolism; D051381:Rats; D011971:Receptors, Immunologic / Q000378:metabolism*; D018110:Receptors, Lipoprotein; D051116:Receptors, Scavenger; D051122:Scavenger Receptors, Class B
D001212:Asialoglycoproteins; D004337:Drug Carriers; D006020:Glycopeptides; D008565:Membrane Proteins; D020319:Oligodeoxyribonucleotides, Antisense; D009961:Orosomucoid; D011971:Receptors, Immunologic; D018110:Receptors, Lipoprotein; D051116:Receptors, Scavenger; C454739:Scarb1 protein, mouse; D051122:Scavenger Receptors, Class B